114 related articles for article (PubMed ID: 10698049)
1. Effect of long-term treatment with recombinant human growth hormone on erythropoietin secretion in an anemic patient with panhypopituitarism.
Sohmiya M; Kato Y
J Endocrinol Invest; 2000 Jan; 23(1):31-6. PubMed ID: 10698049
[TBL] [Abstract][Full Text] [Related]
2. Effect of long-term administration of recombinant human growth hormone (rhGH) on plasma erythropoietin (EPO) and haemoglobin levels in anaemic patients with adult GH deficiency.
Sohmiya M; Kato Y
Clin Endocrinol (Oxf); 2001 Dec; 55(6):749-54. PubMed ID: 11895216
[TBL] [Abstract][Full Text] [Related]
3. Stimulation of erythropoietin secretion by continuous subcutaneous infusion of recombinant human GH in anemic patients with chronic renal failure.
Sohmiya M; Ishikawa K; Kato Y
Eur J Endocrinol; 1998 Mar; 138(3):302-6. PubMed ID: 9539305
[TBL] [Abstract][Full Text] [Related]
4. Human growth hormone and insulin-like growth factor-I inhibit erythropoietin secretion from the kidneys of adult rats.
Sohmiya M; Kato Y
J Endocrinol; 2005 Jan; 184(1):199-207. PubMed ID: 15642796
[TBL] [Abstract][Full Text] [Related]
5. The effects of corticotropin and growth hormone releasing hormones on their respective secretory axes in chronic hemodialysis patients before and after correction of anemia with recombinant human erythropoietin.
Ramirez G; Bittle PA; Sanders H; Rabb HA; Bercu BB
J Clin Endocrinol Metab; 1994 Jan; 78(1):63-9. PubMed ID: 8288716
[TBL] [Abstract][Full Text] [Related]
6. Endocrine effects of erythropoietin in cancer patients.
Lissoni P; Perego M; Veronese E; Fumagalli G; Brivio F; Colciago M; Messina G; Rovelli F; Brivio R; Gardani G
Hematology; 2004; 9(5-6):363-7. PubMed ID: 15763975
[TBL] [Abstract][Full Text] [Related]
7. Long-term effects of recombinant human erythropoietin therapy on growth hormone secretion in uremic patients undergoing peritoneal dialysis.
Díez JJ; Iglesias P; Sastre J; Aguilera A; Bajo MA; Méndez J; Gómez Pan A; Selgas R
Metabolism; 1999 Feb; 48(2):210-6. PubMed ID: 10024084
[TBL] [Abstract][Full Text] [Related]
8. Reduced erythropoietin secretion in senile anemia.
Kario K; Matsuo T; Kodama K; Nakao K; Asada R
Am J Hematol; 1992 Dec; 41(4):252-7. PubMed ID: 1288287
[TBL] [Abstract][Full Text] [Related]
9. Effect of recombinant human GH on circulating granulocyte colony-stimulating factor and neutrophils in patients with adult GH deficiency.
Sohmiya M; Kanazawa I; Kato Y
Eur J Endocrinol; 2005 Feb; 152(2):211-5. PubMed ID: 15745928
[TBL] [Abstract][Full Text] [Related]
10. Serum erythropoietin concentrations in patients with anemia--preliminary hemoglobin-related reference ranges.
Vogeser M; Schiel X
Clin Lab; 2002; 48(11-12):595-8. PubMed ID: 12465743
[TBL] [Abstract][Full Text] [Related]
11. Recombinant human erythropoietin β: the effect of weekly dosing on anemia, quality of life, and long-term outcomes in pediatric cancer patients.
Durmaz O; Demirkaya M; Sevinir B
Pediatr Hematol Oncol; 2011 Sep; 28(6):461-8. PubMed ID: 21707225
[TBL] [Abstract][Full Text] [Related]
12. [Influence of tumor necrosis factor-alpha and interferon-gamma on erythropoietin production and erythropoiesis in cancer patients with anemia].
Wang W; Zhang MH; Yu Y; Xu CG
Zhonghua Xue Ye Xue Za Zhi; 2007 Oct; 28(10):681-4. PubMed ID: 18399174
[TBL] [Abstract][Full Text] [Related]
13. [Subcutaneous administration of recombinant human erythropoietin (R-EPO) in the treatment of anemia in predialysis patients with chronic renal failure].
Debska-Slizień A; Rutkowski B; Niemierko J; Jankowska-Gan E; Gołebiewska-Zurkowska G; Kabata J; Manitius A
Pol Arch Med Wewn; 1991 Jun; 85(6):334-40. PubMed ID: 1896396
[TBL] [Abstract][Full Text] [Related]
14. Serum erythropoietin levels in the elderly.
Kario K; Matsuo T; Nakao K
Gerontology; 1991; 37(6):345-8. PubMed ID: 1765284
[TBL] [Abstract][Full Text] [Related]
15. Suppressed serum erythropoietin response to anemia and the efficacy of recombinant erythropoietin in the anemia of rheumatoid arthritis.
Takashina N; Kondo H; Kashiwazaki S
J Rheumatol; 1990 Jul; 17(7):885-7. PubMed ID: 2213753
[TBL] [Abstract][Full Text] [Related]
16. Recombinant human erythropoietin (rhEPO) treatment potentiates growth hormone (GH) response to growth hormone releasing hormone (GHRH) stimulation in hemodialysis patients.
Cremagnani L; Cantalamessa L; Orsatti A; Vigna L; Vallino F; Buccianti G
Clin Nephrol; 1993 May; 39(5):282-6. PubMed ID: 8513607
[TBL] [Abstract][Full Text] [Related]
17. Erythropoietin production rate in phlebotomy-induced acute anemia.
Al-Huniti NH; Widness JA; Schmidt RL; Veng-Pedersen P
Biopharm Drug Dispos; 2004 Dec; 25(9):389-97. PubMed ID: 15529399
[TBL] [Abstract][Full Text] [Related]
18. Effect of recombinant human growth hormone (rhGH) on hemoglobin concentration in children with idiopathic growth hormone deficiency-related anemia.
Miniero R; Altomare F; Rubino M; Matarazzo P; Montanari C; Petri A; Raiola G; Bona G
J Pediatr Hematol Oncol; 2012 Aug; 34(6):407-11. PubMed ID: 22584781
[TBL] [Abstract][Full Text] [Related]
19. Interpatient variation in response to subcutaneous versus intravenous low dose erythropoietin.
Barclay PG; Fischer ER; Harris DC
Clin Nephrol; 1993 Nov; 40(5):277-80. PubMed ID: 8281716
[TBL] [Abstract][Full Text] [Related]
20. A Novel Hypoxia-Inducible Factor-Prolyl Hydroxylase Inhibitor (GSK1278863) for Anemia in CKD: A 28-Day, Phase 2A Randomized Trial.
Brigandi RA; Johnson B; Oei C; Westerman M; Olbina G; de Zoysa J; Roger SD; Sahay M; Cross N; McMahon L; Guptha V; Smolyarchuk EA; Singh N; Russ SF; Kumar S;
Am J Kidney Dis; 2016 Jun; 67(6):861-71. PubMed ID: 26827289
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
